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Background: Although smoking behavior is known to affect body mass index (BMI), the potential for smoking to
influence genetic associations with BMI is largely unexplored.
Methods: As part of the ‘Population Architecture using Genomics and Epidemiology (PAGE)’ Consortium, we
investigated interaction between genetic risk factors associated with BMI and smoking for 10 single nucleotide
polymorphisms (SNPs) previously identified in genome-wide association studies. We included 6 studies with a total
of 56,466 subjects (16,750 African Americans (AA) and 39,716 European Americans (EA)). We assessed effect
modification by testing an interaction term for each SNP and smoking (current vs. former/never) in the linear
regression and by stratified analyses.
Results: We did not observe strong evidence for interactions and only observed two interactions with p-values <0.1: for
rs6548238/TMEM18, the risk allele (C) was associated with BMI only among AA females who were former/never smokers
(β = 0.018, p = 0.002), vs. current smokers (β = 0.001, p = 0.95, pinteraction = 0.10). For rs9939609/FTO, the A allele was
more strongly associated with BMI among current smoker EA females (β = 0.017, p = 3.5x10-5), vs. former/never smokers
(β = 0.006, p = 0.05, pinteraction = 0.08).
Conclusions: These analyses provide limited evidence that smoking status may modify genetic effects of previously
identified genetic risk factors for BMI. Larger studies are needed to follow up our results.
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The relationship between BMI and smoking is complex.
Genetic variation is partially responsible for determining
BMI, and genome-wide association studies (GWAS)
have identified multiple variants associated with body
mass index (BMI) in novel loci [1]. Lifestyle factors also
play a key role in determining BMI: smoking affects
body fat distribution [2], and current smokers tend to
have lower BMI than non-smokers. The mechanism by
which smoking regulates adiposity likely involves both
appetite suppression via neural pathways [3] and interac-
tions with energy-regulating hormonal feedback loops
[4]. The interrelationship between BMI-setting genetic
pathways and smoking behavior remains to be explored.
This study examines the potential for effect modification
by smoking in the well-replicated association between
GWAS-identified SNPs and BMI, using data derived from
56,466 European American (EA) and African American
(AA) men and women as part of the NHGRI-supported
‘Population Architecture using Genomics and Epidemi-
ology (PAGE)’ Consortium [5]. We hypothesize that gen-
etic associations with BMI may differ by smoking status.
Our results may lead to better understanding of the com-
bined effects of genetics and smoking on obesity among
AA and EA men and women.
Methods
Study populations
PAGE involves several studies, described in detail else-
where [5]. PAGE studies included in this analysis are
Atherosclerosis Risk in Communities Study (ARIC), Cor-
onary Artery Risk in Young Adults (CARDIA), Cardio-
vascular Health Study (CHS), Women’s Health Initiative
(WHI), Multiethnic Cohort (MEC), and Epidemiologic
Architecture for Genes Linked to Environment (EAGLE)
accessing the National Health and Nutrition Examination
Surveys (NHANES). All studies collected self-identified
racial/ethnic group and baseline smoking status via ques-
tionnaire. All studies were approved by Institutional Re-
view Boards at their respective sites, and all participants
provided informed consent.
To reduce the likelihood of including individuals with
extreme BMI due to a comorbid condition or a rare muta-
tion, these analyses only included subjects with BMI ≥18.5
and <70. In our prior analyses, we found that using tighter
BMI restrictions (i.e., BMI <40 and BMI <50) did not sub-
stantially alter results [6]. A total of 56,466 participants
were selected from the PAGE consortium for analysis.
Anthropometric measurements
In MEC, self-reported height and weight were used to
calculate baseline BMI (calculated as weight (kg) ÷
height (m)2). Multiple studies have described systematic
biases in self-reported compared to measured height andweight; yet in general these differences are small (<1.0
kg/m2) and are unlikely to affect any conclusions [7-9].
At all other sites, BMI was calculated from height and
weight measured at study enrollment in a clinic setting,
with the exception of 140 (0.8%) of the 16,836 WHI sub-
jects whose first available measurements were collected
1 or 3 years after enrollment.
SNP selection and genotyping
SNPs were selected from GWAS studies published on-
line as of December 31, 2008, based on prior GWAS
findings of positive association with BMI or obesity. We
analyzed a total of 10 SNPs, after excluding correlated
SNPs. Details of the SNP selection process, DNA extrac-
tion and genotyping procedures, as well as the associ-
ation between each of these SNPs and BMI in PAGE
have been reported elsewhere [6]. Nine SNPs were ana-
lyzed in EA (Table 1), and four SNPs were analyzed in
AA (Table 2). We limited our analyses in each group to
those SNPs previously associated with BMI in that racial/
ethnic group, either in prior GWAS or in our prior report
[10]. We also analyzed rs3751812/FTO in AA because this
SNP has been previously associated with BMI in popula-
tions with African ancestry, although our previous analyses
were underpowered to detect an association [10,11]. We
did not analyze rs3751812/FTO in EA because it is strongly
correlated with rs9939609/FTO in this population.
Statistical analysis
All analyses were adjusted for continuous age and strati-
fied by racial/ethnic group. Because it has been described
that nicotine has antiestrogenic properties and is metabo-
lized differently in men and women, all analyses were
additionally stratified by sex [12]. To evaluate effect modi-
fication by current smoking, we estimated the association
between each SNP and natural log-transformed BMI
(lnBMI) in models using linear regression with robust
standard errors (SEs) [13], and including a SNP*smoking
(current = 1 vs. former/never = 0) interaction term. SNP
genotype was coded assuming an additive genetic model
(i.e., 0, 1, or 2 copies of the coded allele). We obtained
betas specific to current smokers from this model, and to
obtain stratum-specific betas for former/never smokers,
we re-ran each analysis with a reverse-coded smoking
variable (i.e., current = 0 vs. former/never = 1).
To evaluate the association between each SNP and smok-
ing status, we performed logistic regression using current
smoking status as the dependent variable (current = 1 vs.
former/never = 0).
Results (effect sizes and SEs) from each PAGE study
were combined with meta-analysis using R [14]. Fixed-
effects meta-analysis was used to calculate effect sizes
(β for lnBMI) and 95% confidence intervals (CIs) for each
SNP. Within strata defined by racial/ethnic group, smoking
Table 1 Demographic characteristics of PAGE participants, by site, sex, and smoking status
Current smokers, females
European Americans African Americans
total N Mean age (SD) Age range Mean BMI (SD) Max BMI total N Mean age (SD) Age range Mean BMI (SD) Max BM
ARIC 1507 53.6 (5.6) 44-66 25.3 (5.0) 55.2 651 52.7 (5.5) 44-65 28.8 (6.1) 52.4
CARDIA 250 25.3 (3.4) 18-30 23.7 (4.0) 37.8 285 25.5 (3.5) 18-30 26.6 (6.1) 45.85
CHS 299 70.4 (4.1 ) 65 - 86 25.4 (4.6 ) 44.7 68 70.9 (5.3 ) 65 - 86 27.2 (5.4) 50.57
EAGLE 688 43.5 (17.0) 18-85 26.8 (6.2) 53.8 500 41.4 (14.7) 18-90 29.5 (7.1) 61.68
MEC 78 56.1 (7.6) 45-71 25.8 (6.4) 52.6 169 58.4 (8.0) 45-75 28.3 (5.8) 48.1
WHI 1010 64.2 (6.6) 50-79 27.4 (6.3) 68.8 423 59.3 (6.5) 50-77 30.9 (7.0) 63.8
mean BMIpop (SD) mean BMIpop (SD)
Total 3832 26.0 (5.54) 2096 29.0 (6.5)
Former/never smokers, females
European Americans African Americans
total N Mean age (SD) Age range Mean BMI (SD) Max BMI total N Mean age (SD) Age range Mean BMI (SD) Max BMI
ARIC 4537 54.1 (5.7) 44-65 27.1 (5.6) 54.7 1977 53.5 (5.8) 44-66 31.5 (6.5) 65.9
CARDIA 716 25.7 (3.3) 18-30 23.3 (4.0) 37.8 676 24.2 (3.9) 18-30 26.6 (6.2) 45.85
CHS 2214 72.6 (5.5) 65 - 100 26.7 (4.9) 48.3 446 73.3 (5.7) 65 - 93 30.1 (5.8 ) 58.79
EAGLE 3330 54.3 (18.6) 19-90 27.2 (6.2) 64.5 1656 51.0 (14.7) 23-90 30.1 (6.8) 51.7
MEC 579 58.9 (8.3) 45-76 26.1 (5.6) 56.8 718 60.5 (8.9) 45-77 29.2 (5.9) 56.2
WHI 11865 67.3 (6.8) 50-79 29.1 (6.6) 69.5 3538 61.7 (7.1) 50-79 33.4 (7.7) 68.1
mean BMIpop (SD) mean BMIpop (SD)
Total 23241 28.1 (6.1) 9011 31.6 (7.0)
Current smokers, males
European Americans African Americans
total N Mean age (SD) Age range Mean BMI (SD) Max BMI total N Mean age (SD) Age range Mean BMI (SD) Max BMI
ARIC 1337 54.1 (5.6) 44-65 26.5 (4.0) 56.2 622 53.7 (5.9) 44-66 26.3 (4.8) 45.6
CARDIA 242 25.4 (3.4) 18-30 24.2 (3.4) 34.5 208 25.1 (3.5) 18-30 24.0 (3.8) 36.7
CHS 184 71.3 (4.9) 65 - 90 25.3 (3.3 ) 40.7 60 70.0 (4.7 ) 65 - 89 25.9 (4.0 ) 37.65
EAGLE 859 47.1 (17.7) 18-90 26.8 (5.0) 59.6 544 44.0 (14.9) 18-90 26.2 (5.1) 50.41
MEC 68 59.5 (7.8) 45-76 26.5 (3.8) 37 253 61.2 (7.5) 45-76 26.1 (4.0) 45.7
mean BMIpop (SD) mean BMIpop (SD)
Total 2690 26.3 (4.3) 1687 25.9 (4.7)
Former/never smokers, males
European Americans African Americans
total N Mean age (SD) Age range Mean BMI (SD) Max BMI total N Mean age (SD) Age range Mean BMI (SD) Max BMI
ARIC 4089 55.0 (5.7) 44-66 27.7 (4.0) 53.9 1008 54.0 (6.0) 44-66 28.4 (4.8) 54.4
CARDIA 671 25.6 (3.3) 18-30 24.3 (3.2) 34.5 487 24.0 (3.7) 18-30 25.0 (4.0) 36.7
CHS 1778 73.6 (5.7) 65 - 95 26.6 (3.7) 46.2 245 73.3 (5.8 ) 65 - 93 27.2 (4.0 ) 38.16
EAGLE 2812 62.5 (16.9) 18-90 27.66 (4.2) 48.4 1310 53.9 (17.1) 19-87 28.6 (5.9) 46.4
MEC 603 61.9 (8.1) 45-77 26.4 (3.8) 49.6 906 63.8 (7.2) 45-77 27.9 (4.2) 51.2
mean BMIpop (SD) mean BMIpop (SD)
Total 9953 27.0 (3.9) 3956 27.5 (4.5)
ARIC Atherosclerosis Risk in Communities Study, CARDIA Coronary Artery Risk in Young Adults, CHS Cardiovascular Health Study, EAGLE Epidemiologic Architecture for
Genes Linked to Environment, MEC Multiethnic Cohort,WHI Women's Health Initiative, SD standard deviation, BMI: body mass index; Note: minimum BMI was 18.5 for all
sites and ancestry groups.
BMIpop: weighted average of mean BMI reported by each PAGE site.
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Table 2 Complete meta-analysis results in European Americans, effect size expressed in terms of % difference in mean BMI
Current smokers Former/never smokers Combined sex and smoking status*
Gene SNP CA sex p-value for
interaction
% difference in mean BMI
(95% CI)
p-value N % difference in mean BMI
(95% CI)
p-value N % difference in mean BMI
(95% CI)
p-value N AF
MTCH2 rs10838738 G F 0.40 0.6 (-0.4 - 1.51) 0.23 2404 0.4 (-0.2 - 1.11) 0.20 17737 0.51 (0.22 - 0.8) 1.0E-03 34679 0.35
M 0.24 0.3 (-0.5 - 1.11) 0.40 1525 0.8 (0.1 - 1.41) 0.03 4945
GNPDA2 rs10938397 G F 0.87 0.1 (-1.39 - 1.61) 0.88 2165 0.3 (-0.3 - 1.01) 0.28 15961 0.29 (0.004 - 0.69) 0.04 31346 0.43
M 0.63 0.1 (-1 - 1.31) 0.82 1398 0.5 (-0.2 - 1.21) 0.13 3753
KCTD15 rs11084753 G F 0.42 0.8 (0.004 - 1.61) 0.05 3447 −0.1 (-0.7 - 0.4) 0.60 21303 0.11 (-0.18 - 0.4) 6.1E-01 29411 0.67
M 0.46 −0.1 (-0.7 - 0.6) 0.78 2321 0.2 (-0.3 - 0.7) 0.42 7901
MC4R rs12970134 A F 0.30 0.5 (-0.6 - 1.61) 0.38 1619 0.6 (-0.3 - 1.41) 0.20 14992 0.8 (0.29 - 1.2) 1.3E-03 21987 0.26
M 0.64 0.1 (-0.9 - 1.11) 0.85 672 1.11 (-0.3 - 2.53) 0.12 2492
MC4R rs17782313 C F 0.60 0.8 (-0.1 - 1.61) 0.09 3449 0.7 (0.1 - 1.31) 0.02 21334 0.22 (-0.004 - 0.51) 0.08 35398 0.22
M 0.83 0.1 (-0.6 - 0.8) 0.72 2326 0.6 (0.002 - 1.21) 0.05 7930
NEGR1 rs2815752 T F 0.45 0.7 (-0.1 - 1.51) 0.07 3393 0.2 (-0.3 - 0.7) 0.38 20898 0.51 (0.11 - 0.8) 9.2E-03 28261 0.63
M 0.96 0.4 (-0.3 - 1.11) 0.30 2272 0.1 (-0.4 - 0.6) 0.69 7363
TMEM18 rs6548238 C F 0.15 1.11 (0.2 - 2.12) 0.02 3424 1.21 (0.5 - 1.82) 7.0E-04 21261 1.02 (0.62 - 1.42) 8.6E-08 37061 0.83
M 0.69 0.7 (-0.2 - 1.51) 0.12 2290 0.9 (0.2 - 1.51) 0.01 7805
SH2B1 rs7498665 G F 0.47 0.7 (-0.2 - 1.61) 0.11 2400 0.9 (0.3 - 1.51) 6.0E-03 17698 0.22 (-0.11 - 0.62) 2.2E-01 31383 0.38
M 0.49 0.2 (-0.6 - 1.01) 0.67 1530 0.8 (0.1 - 1.51) 0.02 4948
FTO rs9939609 A F 0.08 1.71 (0.9 - 2.53) 3.5E-05 2719 0.6 (-0.01 - 1.11) 0.05 18221 1.31 (1.02 - 1.71) 4.6E-15 28286 0.40
M 0.94 1.31 (0.6 - 1.92) 2.8E-04 1457 1.51 (1.01 - 2.12) 6.9E-08 5671
CA Coded allele, M male, F female, CI confidence interval, AF coded allele frequency.
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(BMIpop) as the weighted average of mean BMIs reported
by each PAGE site (Table 3). We calculated the mean BMI
associated with 1 copy of the risk allele with the following
formula: BMI1RA = exp ( ln (BMIpop) + β ). We then sub-
tracted the BMIpop from BMI1RA to obtain the difference
in mean BMI associated with 1 copy of the risk allele. We
evaluated I2 as a measure of heterogeneity [15], to identify
any excess variation between the PAGE cohorts. To ad-
dress potential population stratification, we repeated ana-
lyses for studies that had Ancestry Informative Markers
(AIMS) (WHI, ARIC, and MEC, representing >70% of sub-
jects) including the most significant principal components
(PCs) derived from AIMs in each model, and compared
the results to unadjusted models.
Finally, as a sensitivity analysis to explore the effect of
age, we repeated all analyses excluding subjects enrolled
in CARDIA, who tended to be younger than subjects en-
rolled at the other PAGE sites (Table 3).
Results
Participant demographics and BMI are detailed in
Table 3. Analyses included a total of 39,716 EA, and
16,750 AA, with BMI ranging from 18.5 – 69.5 kg/m2.
Allele frequencies did not differ substantially by smoking
status or sex, and thus combined frequencies are pre-
sented in all tables. We found no evidence of population
stratification, and the sensitivity analysis revealed that
excluding subjects enrolled in CARDIA (i.e., younger
subjects) did not substantially alter results (data not
shown). Thus, we present results unadjusted for PCs,
and for all available PAGE subjects (Table 3).
Out of all analyses performed in EA and AAs, none of
the SNP*smoking interaction terms were, statistically
significant at p-value ≤ 0.05 (Tables 1 and 2). We
observed only two interactions that had p-values <0.1: In
AA females, the C vs. A allele of rs6548238/TMEM18
was associated with a 1.82% difference in mean BMI in
former/never smokers, compared to a 0.10% difference
in mean BMI in current smokers (pinteraction = 0.10). In
EA men and women, the difference in BMI associated
with the C allele of rs6548238/TMEM18 was very simi-
lar in current smokers and former smokers. Rs6548238/
TMEM18 was not associated with smoking status in any
of the sex/race groups (data not shown).
Further, we observed that in female EA, the A allele of
rs9939609/FTO was almost three-fold more strongly
associated with BMI in current smokers (1.71% differ-
ence in mean BMI) compared with former/never smo-
kers (0.60% difference in mean BMI, (pinteraction = 0.08).
In EA males, there was no difference in the effect of
rs9939609/FTO on BMI by smoking status (p = 0.94).
The A allele of rs9939609/FTO was not associated with
current smoking status in either sex (data not shown).As noted above, rs9939609 was not analyzed in AA due
to lack of evidence for an association between this SNP
and BMI in African ancestry populations.
Discussion
In our results, we found little evidence for effect modifica-
tion by smoking status, although two SNPs (rs6548238/
TMEM18 and rs9939609/FTO) showed weak evidence for
interaction that should be followed up in a larger study.
There was some evidence that the BMI-increasing effect of
the rs6548238/TMEM18 C allele was stronger in AA fe-
male former/never smokers. The function of TMEM18
(transmembrane protein 18) is unknown. TMEM18 is
highly expressed in neural tissue, and has been hypothe-
sized to play a role in energy homeostasis via neural path-
ways controlling food intake [16]. Although TMEM18 has
not been associated with smoking behavior or nicotine me-
tabolism thus far, smoking may modify the effect of
TMEM18 on BMI via energy homeostasis.
The FTO protein may also be involved in neural path-
ways of energy homeostasis [17]. In our analyses of EA
females, the A allele of rs9939609/FTO was more
strongly associated with BMI among current smokers
compared with former/never smokers, although the ana-
lysis was underpowered to detect a statistically signifi-
cant difference between the two groups. If the effect of
this SNP truly differs by smoking status, we still cannot
determine if smoking affects the function of the risk al-
lele, or if the risk allele attenuates smoking behavior.
The latter hypothesis is supported by a study of 6,877
Polish subjects, in which the A allele of rs9939609/FTO
was associated with older age at smoking initiation and
fewer cigarettes smoked per day [18].
Sex-and race/ethnicity-based differences in interaction
with smoking could be attributable to differences in
smoking behavior, such as cigarette brand choice, and
daily vs. occasional “social” smoking [19]. Although we
did not have access to such variables, we found no evi-
dence of heterogeneity that would indicate systematic
between-group differences.
We did not adjust any analyses to account for multiple
testing because we restricted all analyses to SNPs previ-
ously known to be associated with BMI. However, these
unadjusted results may be prone to increased type 1
error and our results should be replicated in future, lar-
ger studies.
Conclusion
We provide an investigation of the hypothesis that genetic
predisposition to obesity may be modified by tobacco use
among EA and AA men and women. We observed no
strong evidence for SNP*smoking interaction. Despite the
relatively large sample size of over 50,000 participants
power was limited and future larger studies should
Table 3 Complete meta-analysis results for African-Americans, effect size expressed in terms of % difference in mean BMI
Current smokers Former/never smokers Combined sex and smoking status*
Gene SNP CA sex p-value for
interaction
% difference in mean
BMI (95% CI)
p-value N % difference in mean
BMI (95% CI)
p-value N % difference in mean
BMI (95% CI)
p-value N AF
GNPDA2 rs10938397 G F 0.60 0.5 (-0.9 - 1.92) 0.50 1848 1.51 (0.6 - 2.43) 9.2E-04 7664 0.91 (0.3 - 1.41) 1.5E-03 14383 0.24
M 0.78 1.31 (-0.1 - 2.63) 0.06 1455 1.51 (0.4 - 2.53) 6.9E-03 2831
MC4R rs17782313 C F 0.53 −0.8 (-2.08 - 0.6) 0.27 1758 0.6 (-0.2 - 1.51) 0.15 7365 0.6 (0.03 - 1.11) 4.0E-02 13698 0.29
M 0.31 −0.1 (-1.29 - 1.21) 0.93 1339 1.21 (0.2 - 2.22) 0.02 2682
FTO rs3751812 T F 0.34 −0.1 (-2.76 - 2.63) 0.94 774 0.4 (-1.09 - 1.92) 0.61 4505 0.4 (-1.11 - 2.01) 0.60 4549 0.12
M 0.61 2.53 (0.2 - 4.92) 3.0E-02 329 1.51 (-0.3 - 3.25) 0.11 565
TMEM18 rs6548238 C F 0.10 0.1 (-1.78 - 2.02) 0.95 1876 1.82 (0.7 - 2.94) 0.002 7707 1.31 (0.6 - 2.01) 2.4E-04 14492 0.88
M 0.64 2.43 (0.7 - 4.08) 0.01 1463 0.9 (-0.4 - 2.22) 0.18 2855
CA Coded allele, M male, F female, CI confidence interval, AF coded allele frequency.
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each variant’s association with energy balance.
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